Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Journal of Cardiovascular Pharmacology|August 3, 2001
Formation of isoprostanes in children with type IIa hypercholesterolemiaJ L Cracowski, D Ploin, J Bessard, et al.
Sleep Medicine|October 4, 2024
Signal detection of drugs associated with obstructive and central sleep apnoeaC Jambon-Barbara, B Revol, A Hlavaty, et al.
Rheumatology (Oxford, England)|May 18, 2006
Digital thermal hyperaemia impairment does not relate to skin fibrosis or macrovascular disease in systemic sclerosisM Salvat-Melis, P H Carpentier, C T Minson, et al.
Neurogastroenterology and Motility|February 28, 2016
Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot studyB Bonaz, V Sinniger, D Hoffmann, et al.
European Radiology|March 31, 2015
Recurrent peripheral vestibulopathy: Is MRI useful for the diagnosis of endolymphatic hydrops in clinical practice?Arnaud Attyé, G Dumas, I Troprès, et al.
The European Respiratory Journal|March 7, 2008
Leukotriene B4: early mediator of atherosclerosis in obstructive sleep apnoea?B Lefebvre, J-L Pépin, J-P Baguet, et al.
Annals of the Rheumatic Diseases|February 3, 2007
Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosisP de Groote, V Gressin, E Hachulla, et al.
Revue Des Maladies Respiratoires|March 16, 2005
[Biomarkers as prognostic factors in pulmonary arterial hypertension. Rationale and study design]J L Cracowski, A Yaici, O Sitbon, et al.
Arthritis and Rheumatism|January 1, 2009
Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosisP Dieudé, M Guedj, J Wipff, et al.
Arthritis and Rheumatism|August 1, 2009
STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosisP Dieudé, M Guedj, J Wipff, et al.
Pageof 9